Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient‐Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis

Patient‐reported outcomes (PROs) are important endpoints for clinical trials. The impact of investigational drugs on PROs of patients with advanced nonalcoholic steatohepatitis (NASH) was investigated. Patients with NASH with bridging fibrosis or compensated cirrhosis were enrolled in a phase 2, ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Younossi, Zobair M., Stepanova, Maria, Noureddin, Mazen, Kowdley, Kris V., Strasser, Simone I., Kohli, Anita, Ruane, Peter, Shiffman, Mitchell L., Sheikh, Aasim, Gunn, Nadege, Caldwell, Stephen H., Huss, Ryan S., Myers, Robert P., Wai‐Sun Wong, Vincent, Alkhouri, Naim, Goodman, Zachary, Loomba, Rohit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279457/
https://www.ncbi.nlm.nih.gov/pubmed/34278169
http://dx.doi.org/10.1002/hep4.1710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279457/
https://www.ncbi.nlm.nih.gov/pubmed/34278169
http://dx.doi.org/10.1002/hep4.1710

Ejemplares similares